Parameter (%) | I. Benlbaghdadi[18] (n = 6) | K. Aoun[10] (n = 18) | M. Afrit[11] (n = 7) | P. Pagliano[19] (n = 64) | Our series (n = 26) |
---|---|---|---|---|---|
Fever | 100 | 83 | 100 | 94 | 92 |
Splenomegaly | 83 | 55 | 57 | 100 | 84 |
Hepatomegaly | 50 | 38 | 57 | 100 | 35 |
Pallor | 100 | 94 | Â | Â | 100 |
Haemorrhage | 17 | Â | Â | Â | 35 |
Lymphadenopathy | Â | 33 | 14 | Â | 35 |
Pancytopenia | 83 | 22 | 57 | Â | 56 |
Inflammatory syndrome | 100 | 83 | 71 | Â | 100 |
Hyperproteinemia | 50 | Â | Â | Â | 27 |
Hypergammaglobulinemia | 100 | 94 | 57 | Â | Â |
Anti-Leishmania serology (+) | 83 | 82 | 83 | 100 | 92 |
Amastigotes on bone marrow smears | 50 | 67 | 100 | 97 | 92 |
Favorable outcome | 83 | Â | 71 | Â | 88 |
Deaths | 1 case (Hematemesis: PHT) | Â | 1 case (Severe sepsis) | 1 case (Relapse) | 1 case (unexplained) |